Goodrx Holdings 

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$203,070
$202,970
$198,583
$195,251
Gross Profit
169,991
189,606
186,390
183,567
EBITDA
50,035
48,224
41,863
38,002
EBIT
30,306
27,312
22,767
20,467
Net Income
12,843
11,052
6,740
12,259
Net Change In Cash
203,070
202,970
198,583
195,251
Free Cash Flow
49,190
9,271
28,099
71,003
Cash
281,318
300,981
448,346
423,777
Basic Shares
357,159
379,656
383,576
388,504

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$792,324
$750,265
$766,554
$745,424
Gross Profit
744,109
683,340
701,475
698,708
EBITDA
153,920
108,824
68,538
48,004
EBIT
84,382
1,156
11,012
10,363
Net Income
16,390
-8,868
-32,828
-25,254
Net Change In Cash
792,324
750,265
766,554
745,424
Cost of Revenue
-183,944
-30,482
Free Cash Flow
113,545
82,526
91,566
144,322
Cash
448,346
672,296
757,165
941,109
Basic Shares
392,172
410,315
412,858
400,562

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
$0.09
2025-03-31
$0.09
2024-12-31
$0.09